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Abstract
Most existing methods for biomedical entity recognition task rely on explicit feature
engineering where many features either are specific to a particular task or depends
on output of other existing NLP tools. Neural architectures have been shown across
various domains that efforts for explicit feature design can be reduced. In this work
we propose an unified framework using bi-directional long short term memory net-
work (BLSTM) for named entity recognition (NER) tasks in biomedical and clinical
domains. Three important characteristics of the framework are as follows - (1) model
learns contextual as well as morphological features using two different BLSTM in hi-
erarchy, (2) model uses first order linear conditional random field (CRF) in its output
layer in cascade of BLSTM to infer label or tag sequence, (3) model does not use any
domain specific features or dictionary, i.e., in another words, same set of features are
used in the three NER tasks, namely, disease name recognition (Disease NER), drug
name recognition (Drug NER) and clinical entity recognition (Clinical NER). We com-
pare performance of the proposed model with existing state-of-the-art models on the
standard benchmark datasets of the three tasks. We show empirically that the proposed
framework outperforms all existing models. Further our analysis of CRF layer and
word-embedding obtained using character based embedding show their importance.
Keywords: Drug Name Recognition, Disease Name Recognition,
Clinical Entity Recognition, Recurrent Neural Network,
LSTM Network
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1. Introduction
Biomedical and clinical named entity recognition (NER) in text is one of the im-
portant step in several biomedical and clinical information extraction tasks [1, 2, 3].
State-of-art methods formulated NER task as a sequence labeling problem where each
word is labeled with a tag and based on tag sequence entities of interest get identified.
It has been observed that named entity recognition in biomedical and clinical domain is
difficult [4, 5] compared to the generic domain. There are several reasons behind this,
including use of non standard abbreviations or acronyms, multiple variations of same
entities etc. Further clinical notes are more noisy, grammatically error prone and con-
tain less context due to shorter and incomplete sentences [3]. Most widely used models
such as CRF, maximum entropy Markov model (MEMM) or support vector machine
(SVM), use manually designed rules to obtain morphological, syntactic, semantic and
contextual information of a word or of a piece of text surrounding a word, and use them
as features for identifying correct label [6, 7, 8, 9, 10]. It has been observed that perfor-
mance of such models are limited with the choice of explicitly designed features which
are generally specific to task and its corresponding domain. For example, Chawdhury
and Lavelli [7] explained several reasons why features designed for biological entities
such as protein or gene are not equally important for disease name recognition.
Deep learning based models have been used to reduce manual efforts for explicit
feature design in [11]. Here distributional features were used in place of manually
designed features and multilayer neural network were used in place of linear model
to overcome the needs of task specific meticulous feature engineering. Although pro-
posed methods outperformed several generic domain sequence tagging tasks but it fails
to overcome state-of-art in biomedical domain [12]. There are two plausible reasons
behind that, first, it learned features only from a word level embedding and second,
it took into account only a fixed length context of the word. It has been observed that
word level embeddings preserve syntactic and semantic properties of word, but may fail
to preserve morphological information which can also play important role in biomed-
ical entity recognition [13, 14, 7, 15]. For instance, drug names Cefaclor, Cefdinir,
Cefixime, Cefprozil, Cephalexin have common prefix and Doxycycline, Minocycline,
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Tetracycline have common suffix. Further, window based neural architecture can only
consider contexts falling within the user decided window size and will fail to pick im-
portant clues lying outside the window.
This work aims to overcome the above mentioned two issues. The first one to
obtain both morphologically as well as syntactic and semantically rich embedding, two
BLSTMs are used in hierarchy. First BLSTM works on each character of words and
obtain morphologically rich word embedding. Second BLSTM works at word level
of a sentence to learn contextually reach feature vectors. The second one to make
sure all context lying anywhere in the sentence should be utilized, we consider entire
sentence as input and use first-order linear chain CRF in the final prediction layer.
The CRF layer accommodates dependency information about tags. We evaluate the
proposed model on three standard biomedical entity recognition tasks namely Disease
NER, Drug NER and Clinical NER. To the best of our knowledge this is the first work
which explores single model using character based word embedding in conjunction
with word embedding for drug and clinical entity recognition tasks. We compare the
proposed model with the existing state-of-the-art models for each task and show that
it outperforms them. Further analysis of the model indicates the importance of using
character based word embedding along with word embedding and CRF layer in the
final output layer.
2. Method
2.1. Bidirectional Long Short Term Memory
Recurrent neural network (RNN) is a variant of neural networks which utilizes se-
quential information and maintains history through its recurrent connection [16, 17].
RNN can be used for a sequence of any length, however in practice it fails to main-
tain long term dependency due to vanishing and exploding gradient problems [18, 19].
Long short term memory (LSTM) network [20] is a variant of RNN which takes care of
the issues associated with vanilla RNN by using three gates (input, output and forget)
and a memory cell.
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We formally describe the basic equations pertaining to LSTM model. Let h(t−1)
and c(t−1) be hidden and cell states of LSTM respectively at time t− 1, then computa-
tion of current hidden state at time t can be given as:
i(t) = σ(U (i)x(t) +W (i)h(t−1) + bi)
f (t) = σ(U (f)x(t) +W (f)h(t−1) + bf )
o(t) = σ(U (o)x(t) +W (o)h(t−1) + bo)
g(t) = tanh(U
(g)
l x
(t) +W (g)h(t−1) + bg)
c(t) = c(t−1) ∗ f (t) + g(t) ∗ i(t)
h(t) = tanh(c(t)) ∗ o(t),
where σ is sigmoid activation function, ∗ is an element wise product, x(t) ∈ Rd is the
input vector at time t, U (i), U (f), U (o), U (g) ∈ RN×d, W (i), W (o), W (f), W (g) ∈
RN×N , bi, bf , bo, bg ∈ RN , h(0), c(0) ∈ RN are learning parameters for LSTM. Here d
is dimension of input feature vector, N is hidden layer size and h(t) is output of LSTM
at time step t.
It has become common practice to use LSTM in both forward and backward direc-
tions to capture both past and future contexts respectively. First LSTM computes its
hidden states in forward direction of input sequence and second does it in backward
direction. This way of using two LSTMs is referred to as bidirectional LSTM or sim-
ply BLSTM. We have also used bi-directional LSTM in our model. Final output of
BLSTM at time t is given as:
h(t) =
−→
h(t) ⊕
←−
h(t) (1)
Where ⊕ is concatenation operation and
−→
h(t) and
←−
h(t) are hidden states of forward and
backward LSTM at time t.
2.2. Model Architecture
Similar to any named entity recognition task, we formulate the biomedical en-
tity recognition task as a token level sequence tagging problem. We use BIO tagging
scheme in our experiments [21]. Architecture of the proposed model is presented in
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Figure 1: Bidirectional recurrent neural network based model for biomedical entity recognition. Here
w1w2...wm is the word sequence of the sentence and t1 t2 ... tm is its computed label sequence and
m represents length of the sentence.
Figure 1. Our model takes whole sentence as input and compute a label sequence
as output. First layer of the model learns local feature vectors for each word in the
sentence. We use concatenation of word embedding, PoS tag embedding and charac-
ter based word embedding as a local feature for every word. Character based word
embedding is learned through applying a BLSTM on the character vectors of a word.
We call this layer as Char BLSTM ( § 2.3.1 ). Subsequent layer, called Word BLSTM
( § 2.5), incorporates contextual information on it through a separate BLSTM network.
Finally we use a CRF to encode correct label sequence on the output of Word BLSTM
( § 2.5 ). Now onwards, the proposed framework will be referred to as CWBLSTM.
Entire network parameters are trained in end-to-end manner through cross entropy loss
function. We next describe each part of the model in detail.
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2.3. Features Layer
Word embedding or distributed word representation is a compact vector represent
of a word which preserve lexico-semantic properties [22]. It is a common practice to
initialize word embedding with a pre-trained vector representation of words. Apart
from word embedding in this work PoS tag and character based word embedding are
used as features. The output of feature layer is a sequence of vectors say x1, · · ·xm for
the sentence of length m. Here xi ∈ Rd is the concatenation of word embedding, PoS
tag embedding and character based word embedding. We next explain how character
based word embedding is learned.
2.3.1. Char BLSTM
Word embedding is crucial component for all deep learning based NLP task. Ca-
pability to preserve lexico-semantic properties in vector representation of a word made
it a powerful resource for NLP [11, 23]. In biomedical and clinical entity recognition
tasks apart from semantic information, morphological structure such as prefix, suffix
or some standard patterns of words also give important clues [7, 4]. The motivation
behind using character based word embedding is to incorporate morphological infor-
mation of words in feature vectors.
To learn character based embeddings, we maintained a vector for every characters
in a embedding matrix [13, 14]. These vectors are initialized with random values in
the beginning. To illustrate, suppose cancer is a word for which we want to learn an
embedding (represented in figure 2), we use a BLSTM on the vector of each char-
acters of cancer. As mentioned earlier forward LSTM maintained information about
past in computation of current hidden state and backward LSTM obtained futures con-
texts, therefore after reading entire sequence, last hidden states of both RNN must have
knowledge of whole word with respect to their directions. The final embedding of a
word would be:
vcw =
−−→
h(m) ⊕
←−−
h(m) (2)
Where
−−→
h(m) and
←−−
h(m) is the last hidden states of forward and backward LSTMs respec-
tively.
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Figure 2: Learning character based word embedding
2.4. Word BLSTM Layer
The output of feature layer is a sequence of vectors for each word of the sentence.
These vectors have local or individual information about the words. Although local
information plays important role in identifying entities, but a word can have different
meaning in different contexts. Earlier works in [11, 15, 7, 12] use a fixed length window
to incorporate contextual information. However important clues can lie anywhere in
the whole sentence. This limit the learned vectors to obtain knowledge about complete
sentence. To overcome this, we use a separate BLSTM network which takes local
feature vectors as input and outputs a vector for every word based on both contexts and
current feature vectors.
2.5. CRF Layer
The output of Word BLSTM layer is again a sequence of vectors which have con-
textual as well as local information. One simple way to decode the feature vector of a
word into its corresponding tag is to use word level log likelihood (WLL) [11]. Similar
to MEMM’s it will map the feature vector of a word to a score vector of each tag by
a linear transformation and every word will get its label based on its scores and inde-
pendent of labels of other words. One limitation of this way of decoding is it does
not take into account dependency among tags. For instance in BIO tagging scheme
a word can only be tagged with I-Entity (standing for Intermediate-Entity) only after
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a B-Entity (standing for Beginning-Entity). We use CRF [6] on the feature vectors to
include dependency information in decoding and decode whole sentence together with
its tag sequence.
CRF maintained two parameters for decoding, Wu ∈ Rk×h linear mapping pa-
rameter and T ∈ Rh×h pairwise transition score matrix. Here k is the size of feature
vector, h is the number of labels present in task and Ti,j implies pair wise transition
score for moving from label i to label j. Let [v]|s|1 be a sequence of feature vectors for a
sentence [w]|s|1 and suppose [z]
|s|
1 is the unary potential scores obtained after applying
linear transformation on feature vectors (here zi ∈ Rh) then CRF decodes this with tag
sequence using:
P ([y]
|s|
1 |[w]|s|1 ) = argmax
t∈Q|s|
exp Ψ([z]
|s|
1 , [t]
|s|
1 )∑
tψ∈Q|s| exp Ψ([z]
|s|
1 , [t
ψ]
|s|
1 )
(3)
where
Ψ([z]
|s|
1 , [t]
|s|
1 ) =
∑
1≤i≤|s|
(Tti−1,ti + zti) (4)
Here Q|s| is a set contain all possible tag sequence of length |s|, tj is tag for the jth
word. Highest probable tag sequence is estimated using Viterbi algorithm [24, 11].
2.6. Training and Implementation
We use cross entropy loss function to train the model. Adam’s technique [25] is
used for updating entire neural network and embedding parameters of our model. We
use mini batch size of 50 in training for all tasks. Entire implementation is done in
python language using Tensorflow1 package. In all our experiments, we use pre-trained
word embedding of length 100, which was trained on PubMed corpus using GloVe
[26, 27], PoS tag embedding vector of length 10 and character based word embedding
of length 20. We used l2 regularization with 0.001 as corresponding parameter value.
These hyperparameters are obtained using validation set of Disease NER task. The
corresponding training, validation and test sets for Disease NER task is available as
separate files with NCBI disease corpus. For the other two tasks, we used the same set
of hyperparameters as obtained on Disease NER.
1https://www.tensorflow.org
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3. The Benchmark Tasks
In this section, we briefly describe the three standard tasks on which we examine
the CWBLSTM model. Statistics of corresponding benchmark datasets is given in
Table 1.
3.1. Disease NER
Identifying disease named entity in text is crucial for disease related knowledge
extraction [28, 29]. Furthermore, It has been observed that disease is one of the most
widely searched entities by users on PubMed [30]. We use NCBI disease corpus2 to
investigate performance of the model on Disease NER task. This dataset was annotated
by a team of 12 annotators (2 persons per annotation) on 793 PubMed abstracts [30,
31].
3.2. Drug NER
Identifying drug name or pharmacological substance are important first step for
drug drug interaction extraction and for other drug related knowledge extraction tasks.
Keeping this in mind a challenge for recognition and classification of pharmacological
substances in text was organized as part of SemEval 2013. We use SemEval-2013
task 9.1 [32] dataset for this task. The dataset shared in this challenge were annotated
from two sources DrugBank3 documents and MedLine4 abstracts. This dataset has four
kind of drugs as entities, namely drug, brand, group and drug n. Here drug represent
generic drug name, brand is brand name of a drug, group is family name of drugs
and drug n is active substance not approved for human use [33]. In this case while
processing the dataset, 79 entities (56 drug, 18 group and 5 brand) from training set
and 5 entities (4 drug and 1 group) from test set were missed. Missed entities of test
set are treated as false negative in our evaluation scheme.
2https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/
3https://www.drugbank.ca/
4https://www.nlm.nih.gov/bsd/pmresources.html
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Dataset Corpus Train set Test set
Disease NER
sentences 5661 961
disease 5148 961
Drug NER
sentences 6976 665
drug 9369 347
brand 1432 59
group 3381 154
drug n 504 120
Clinical NER
sentences 8453 14529
problem 7072 12592
treatment 2841 9344
test 4606 9225
Table 1: Statistics of benchmark datasets for the three tasks used in the study.
3.3. Clinical NER
For clinical entity recognition we used publicly available (under license) i2b2/VA5
challenge dataset [3, 5]. This dataset is a collection of discharge summaries obtained
from Partners Healthcare, Beth Israel Deaconess Medical Center, and the University of
Pittsburgh Medical Center. The dataset was annotated for three kinds of entities namely
problem, treatment and test. Here problems indicate phrases that contain observations
made by patients or clinicians about the patient’s body or mind that are thought to
be abnormal or caused by a disease. Treatments are phrases that describe procedures,
interventions, and substances given to a patient in an effort to resolve a medical prob-
lem. Tests are procedures, panels, and measures that are done to a patient or a body
fluid or sample in order to discover, rule out, or find more information about a medical
problem.
The downloaded dataset for this task was only partially available (only discharge
summaries from Partners Healthcare and Beth Israel Deaconess Medical Center) com-
5https://www.i2b2.org/NLP/Relations/Main.php
10
pared to the full dataset originally used in the challenge. We performed our experiments
on currently available partial dataset. The dataset is available in pre-processed form,
where sentence and word segmentations were alredy done. We removed patient’s in-
formation from each discharge summary before training and testing, because that never
contains entities of interest.
4. Results and Discussion
4.1. Experiment Design
We perform separate experiments for each task. We use train set for learning opti-
mal parameters of the model for each dataset and evaluation is performed on test set.
Performance of each trained model is evaluated based on strict matching sense, where
exact boundaries as well as class need to be correctly identified for consideration of
true positive. For strict matching evaluation scheme, we use CoNLL 20046 evaluation
script to calculate precision, recall and F1 score in each task.
4.2. Baseline Methods
We use following methods as a common baseline for comparison with the proposed
models in all of the considered tasks. The selected baseline methods are implemented
by us:
SENNA: SENNA uses window based neural network on embedding of a word with
its context to learn global feature [11]. To make inference it also uses CRF on the output
of window based neural network. We set the window size 5 based on hyperparameter
tuning using validation set (20% of training set), and rest all the hyperparameters are
set similar to our model.
CharWNN: This model [13] is similar to SENNA but uses word as well as char-
acter based embedding in the chosen context window [34]. Here character based em-
beddings are learned through convolution neural network with max pooling scheme.
6http://www.cnts.ua.ac.be/conll2002/ner/bin/conlleval.txt
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Tasks Models Accuracy Precision Recall F1 Score
Disease NER
SENNA 97.26 77.93 76.80 77.36
CharWNN 97.24 78.34 78.67 78.50
CharCNN 97.61 84.26 78.56 81.31
CWBLSTM 97.77 84.42 82.31 83.35
Drug NER
SENNA 96.71 66.93 62.70 64.75
CharWNN 97.07 69.16 69.16 69.16
CharCNN 97.09 70.34 72.10 71.21
CWBLSTM 97.46 72.57 74.60 73.57
Clinical NER
SENNA 91.56 80.30 78.85 79.56
CharWNN 91.42 79.96 78.12 79.03
CharCNN 93.02 83.65 83.25 83.45
CWBLSTM 93.19 84.17 83.20 83.68
Table 2: Performance comparison of the proposed model CWBLSTM with baseline models on test set of
different datasets. Here Accuracy represents token level accuracy in tagging.
CharCNN: This method [35] is similar to the proposed model CWBLSTM but
instead of using BLSTM, it uses convolution neural network for learning character
based embedding.
4.3. Comparison with Baseline
Table 2 presents comparison of CWBLSTM with different baseline methods on dis-
ease, drug and clinical entity recognition tasks. We can observe that it outperforms all
three baselines in each of the three tasks. In particular, when comparing with Char-
CNN, differences are significant for Drug NER and Disease NER tasks but difference
is insignificant for Clinical NER. The proposed model improved the recall by 5% to
gain about 2.5% of relative improvement in F1 score over the second best method
CharCNN for the Disease NER task. For the Drug NER task, relative improvement of
more than 3% is observed for all three measures, precision, recall and F1 score over
the CharCNN model. The relatively weaker performance on Clinical NER task could
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Model Features Precision Recall F Score
CWBLSTM Word, PoS and Character Embedding 84.42 82.31 83.35
BANNER[30] Orthographic, morphological, syntactic - - 81.8
BLSTM+We[35] Word Embedding 84.87 74.11 79.13
Table 3: Performance comparison of CWBLSTM with other existing models on Disease NER task
be attributed to use of many non standard acronyms and abbreviations which makes it
difficult for character based embedding models to learn appropriate representation.
One can also observe that, even though Drug NER has sufficiently enough train-
ing dataset, all models gave relatively poor performance compared to the performance
in other two tasks. One reason for the poor performance could be the nature of the
dataset. As discussed Drug NER dataset constitutes texts from two sources, DrugBank
and MedLine. Sentences from DrugBank are shorter and are comprehensive as written
by medical practitioners, whereas MedLine sentences are from research articles which
generally tend to be longer. Further the training set constitutes 5675 sentences from
DrugBank and 1301 from MedLine, whereas test set this distribution is reversed, i.e.
more sentences are from MedLine (520 in comparison to 145 sentences from Drug-
Bank). Smaller set of training instances from MedLine sentences do not give sufficient
examples to model to learn.
4.4. Comparison with Other Methods
In this section we compare our results with other existing methods present in lit-
erature. We do not compare results on Clinical NER as the complete dataset (as was
available in i2b2 challenge) is not available and results in literature are with respect to
the complete dataset.
Disease NER
Table 3 shows performance comparison of different existing methods with CW-
BLSTM on NCBI disease corpus. CWBLSTM improved the performance of BANNER
by 1.89% in terms of F1 Score. BANNER is a CRF based method which primarily
uses orthographic, morphological and shallow syntactic features [15]. Many of these
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Model Features Precision Recall F Score
CWBLSTM Word,PoS and Character Embedding 72.57 74.05 73.30
WBI[9] ChemSpot and Ontologies 73.40 69.80 71.5
LASIGE[37] Ontology and Morphological 69.60 62.10 65.6
UTurku[10] Syntactic and Contextual 73.70 57.90 64.8
Table 4: Performance comparison CWBLSTM with other existing models submitted in SemEval-2013 Drug
NER task
features are specially designed for biomedical entity recognition tasks. The proposed
model also gave better performance than another BLSTM based model [35] by im-
proving recall by around 12%. BLSTM model in [35] used BLSTM network with
word embedding only whereas the proposed model make use of extra features in terms
of PoS as well as character based word embeddings.
Drug NER
Table 4 reports performance comparison on Drug NER task with submitted results
in SemEval-2013 Drug Named Recognition Challenge [32]. CWBLSTM outperforms
the best result obtained in the challenge (WBI-NER[9]) by a margin of 1.8%. WBI-NER
is the extension of ChemSpot chemical NER[36] system which is a hybrid method for
chemical entity recognition. ChemSpot primarily uses features from dictionary to make
sequence classifier using CRF. Apart from that WBI-NER also used features obtained
from different domain dependent ontologies. Performance of the proposed model is
better than LASIGE [37] as well as UTurku [10] system’s by a significant margin.
LASIGE is also a CRF based method and UTurku uses Turku Event Extraction System
(TEES), which is a kernel based model for entity and relation exaction tasks.
4.5. Feature Ablation Study
We analyze importance of each feature type by performing feature ablation. The
corresponding results are presented in Table 5. In this table first row present perfor-
mance of the proposed model using all feature types in all three tasks and second,
third and fourth rows shows performance when character based word embedding, PoS
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Model Disease NER Drug NER Clinical NER
CWBLSTM (84.42), (82.31), (83.35) (72.57), (74.60), (73.57) (84.17), (83.20), (83.68)
- CE (80.86), (80.02), (80.44) (64.29), (75.62), (69.50) (83.76), (81.74), (82.74)
- (CE+PE) (82.72), (77.73), (80.15) (65.96), (73.42), (69.49) (83.31), (80.51), (81.89)
- (CE+PE+WE) (79.66), (73.78), (76.61) (65.40), (55.80), (60.22) (79.53), (78.28), (78.90)
Table 5: Table explain contribution of each features on different datasets. In every block (X), (Y), (Z) implies
precision, recall and F score respectively. Here in row 4 model uses random vector in place of pre-trained
word vectors for word embedding.
Dataset Unique Words OoV Percent
Disease NER 8270 819 9.90
Drug NER 9447 1309 13.85
Clinical NER 13000 2617 20.13
Table 6: Statistics of number of words not found in word embedding file. Here OoV indicates number of
words not found in pre-trained word embedding and percent indicates its percentage over all vocabulary.
tag embeddings and pre-trained word embedding are removed from the model subse-
quently. Removal of pre-trained word embedding implies use of random vectors in
place of pre-trained vectors.
Through the table we can observe that after removal of character based word em-
bedding, 3.6%, 5.8% and 1.1% relative decrements in F1 Score on Disease NER and
Drug NER and Clinical NER tasks are observed. This demonstrate the importance of
character based embedding. As mentioned earlier character based word embedding
helps our model in two ways, first, it gives morphologically rich vector representation
and secondly, through character based word embedding we can get vector represen-
tation for OoV (out of vocabulary) words also. OoV words are 9.9%, 13.85% and
20.13% in Drug NER, Disease NER and Clinical NER dataset respectively (shown in
table 6). As discussed earlier this decrements are less in Clinical NER because of pres-
ence of acronyms and abbreviations in high frequency which does not allow model to
take advantage of character based word embedding. Through third row we can also ob-
serve that using PoS tag embedding as feature is not so crucial in all three tasks. This
is because distributed word embedding implicitly preserve that kind of information.
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In contrast to PoS tag embedding, we observe that use of pre-trained word embed-
ding is the one of the important feature type in our model for each task. Pre-trained
word embedding helps model to get better representation for rare words in training
dataset.
4.6. Effects of CRF and BLSTM
We also analyze the unified framework to gain insight on the effect of using dif-
ferent loss function in the output layer (CRF vs. WLL) as well as effect of using
bi-directional or uni-directional (forward) LSTM. For this analysis, we modify our
framework and named model variants as follows: bi-directional LSTM with WLL out-
put layer is called BLSTM+WLL and uni-directional or regular LSTM with WLL layer
is called LSTM+WLL. In other words BLSTM+WLL model uses all the features of the
proposed framework except it uses WLL in place of CRF. Similarly LSTM+WLL also
uses all features along with forward LSTM instead of bidirectional LSTM and WLL
in place of CRF. Results are presented in table 7. A relative decrement of 7.5%, 3.4%
and 5.5% in obtained F Score on Disease NER, Drug NER and Clinical NER respec-
tively by BLSTM+WLL compared to the proposed model demonstrate the importance
of using CRF layer. This suggests that identifying tag independently is not favored by
the model and it is better to utilize the implicit tag dependency. Further observation
of average token length of a entity in three tasks indicates plausible reason for differ-
ence in performance in the three tasks. Average token length are 1.2 for drug entities,
2.1 for clinical and 2.2 for disease named entities. The longer the average length of
entities, better the performance of model utilizing tag dependency. Similarly relative
improvements of 12.89%, 4.86% and 20.83% in F1 score on Disease NER, Drug NER
and Clinical NER tasks respectively are observed when compared with LSTM + WLL.
This clearly indicates that the use of bi-directional LSTM is always advantageous.
4.7. Analysis of Learned Word Embeddings
Next we analyze characteristics of learned word embeddings after training of the
proposed model. As mentioned earlier, we are learning two different representations
of each word, one through its characters and other through distributional contexts. Our
16
Model Disease NER Drug NER Clinical NER
CWBLSTM (84.42), (82.31), (83.35) (72.57), (74.60), (73.57) (84.17), (83.20), (83.68)
BLSTM+WLL (76.04), (78.25), (77.13) (71.81), (70.34), (71.07) (77.35), (80.91), (79.09)
LSTM+WLL (64.72), (77.32), (70.46) (68.41), (69.02), (68.71) (58.32), (68.11), (62.83)
Table 7: Effect of using CRF and WLL in output layer on performance of the proposed model on different
datasets. In every block (X), (Y), (Z) implies precision, recall and F1 score respectively.
Word Char BLSTM GloVe
2C19 2C9, 2C8/9, 29, 28.9, 2.9z NA
synergistic septic, symptomatic, synaptic, seroton-
ergic, synthetic
synergism, synergy, antagonistic,
dose-dependent, exerts
dysfunction dysregulation, desensitization, dissolu-
tion, addition, admistration
impairment, impaired, disturbances,
deterioration, insufficiency
false-positive false-negative, facultative, five, folate,
facilitate
false, falsely, erroneous, detecting, un-
reliable
micrograms/mL microg/mL micromol/L micro-
grams/ml mg/mL mimicked
NA
Table 8: Word and its 5 nearest neighbors (from left to right increasing order of euclidean distance) learned
by character level word embedding of our model on Drug NER corpus. NA implies word is not present in
list
expectation is that the word embedding obtained through character embeddings will
focus on morphological aspects whereas distributional word embedding on semantic
and syntactic contexts.
We obtain character based word embedding for each word of the Drug NER dataset
after training. We picked 5 words from test set of vocabulary list and observe its 5
nearest neighbors in vocabulary list of training set. The nearest neighbors are selected
using both word-embeddings and results are shown in Table 8. We can observe that the
character based word embedding primarily focus on morphologically similar words,
whereas distributional word embeddings preserve semantic properties. This clearly
suggests that it is important to use the complementary nature of the two embeddings.
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5. Conclusion
In this research we present a unified model for drug, disease and clinical entity
recognition tasks. Our model, called CWBLSTM, uses BLSTMs in hierarchy to learn
better feature representation and CRF to infer correct labels for each word in the sen-
tence at once. We believe, to the best of our knowledge, this is the first work using char-
acter based embeddings in drug and clinical entity recognition tasks. CWBLSTM out-
performs task specific as well as task independent baselines in all three tasks. Through
various analyses we demonstrated the importance of each feature type used by CW-
BLSTM. Our analyses suggest that pre-trained word embeddings and character based
word embedding play complementary roles and along with incorporation of tag de-
pendency are important ingredients for improving the performance of NER tasks in
biomedical and clinical domains.
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